JPRN-jRCTs071180040进行中（未招募）2 期
Treatment protocol for acute promyelocytic leukemia - FBMTG APL2017
Takase Ken0 个研究点目标入组 50 人开始时间: 2019年3月13日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 15age old 至 <= 80age old（—）
- 性别
- All
入选标准
- •1. Acute promyelocytic leukemia by WHO classification
- •2. The first time treatment example which does not catch chemotherapy or the radiotherapy
- •3. The case that is equal to or less than 80 years old more than age 15 years old
- •4. Performance status 0-2
- •5. A case without the dangerously ill internal organs disorder
- •6. The case that an agreement by the document is provided from a patient on explanation because of final examination contents
排除标准
- •1. The case having double cancers
- •2. The case with an infectious disease having difficulty with control
- •3. The case with a severe mental disorder
- •4. The pregnancy or breast-feeding woman
- •5. The case that the medical attendant judged to be inappropriate
研究者
相似试验
已完成
不适用
Treatment protocol for acute promyelocytic leukemia -FBMTG-APL2009acute promyelocytic leukemiaJPRN-UMIN000001742Fukuoka Blood & Marrow Transplant Group50
招募中
不适用
Treatment protocol for acute promyelocytic leukemia FBMTG APL2017acute promyelocytic leukemiaJPRN-UMIN000025044FBMTG50
招募中
3 期
Acute Lymphoblastic Leukemia treatment protocol for children and adolescentRBR-6pmfz8Sociedade Brasileira de Oncologia Pediátrica (SOBOPE)
Unknown
4 期
Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With ArsenicRelapsed Acute Promyelocytic LeukemiaRefractory Acute Promyelocytic LeukemiaNCT00196768German AML Cooperative Group30
已完成
不适用
Risk adapted treatment of Acute Myelocytic Leukaemia (AML)Acute Myeloid Leukaemia (AML)CancerISRCTN76815071Dutch Haemato-Oncology Association (Stichting Hemato-Oncologie Volwassenen Nederland) (HOVON) (Netherlands)1,105